TC
Tessie M Che
COO and SVP

Tessie M Che insider trades: Optimer Pharmaceuticals (OPTR) stock purchases

COO and SVP, Optimer Pharmaceuticals Last trade Dec 29, 2009 37 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2007
2
Companies
last trade 2009

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Tessie reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 29, 2009OPTR↑ Buy$195K
Nov 25, 2009OPTR↑ Buy$173K
Jun 13, 2008OPTR↑ Buy$35K
May 15, 2008OPTR↑ Buy$15K
May 15, 2008OPTR↑ Buy$12K
Nov 15, 2007OPTR↑ Buy$6K
Nov 15, 2007OPTR↑ Buy$6K
Aug 9, 2007OPTR↑ Buy$246K
Aug 6, 2007OPTR↑ Buy$189K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Tessie M Che's insider trades

Tessie M Che is COO and SVP at Optimer Pharmaceuticals (OPTR). Since Aug 6, 2007, Tessie has reported 9 open-market purchases worth $877K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (17 filings), other transactions (7 filings), option exercises (5 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPTR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.